Pediatric Heart Transplantation: Transitioning to Adult Care
NCT ID: NCT02090257
Last Updated: 2017-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2014-03-01
2017-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pediatric -Adult Care Transition Program of Patients With Sickle Cell Disease
NCT03786549
iPeer2Peer Pediatric Thoracic Transplantation
NCT04253548
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
NCT07349498
Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation (CTL-ADV)
NCT02851576
Problem-Solving Education for Caregivers and Patients During Stem Cell Transplant
NCT00766883
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TRANSIT, behavioral
The intervention group will receive more guidance during their transition from a pediatric center to the adult center
TRANSIT
Educational Modules, staff follow up.
Usual Care Group
The usual care group will receive a standard transfer of care from a pediatric center to an adult center.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TRANSIT
Educational Modules, staff follow up.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years or older;
* Able to speak, read at a fifth grade level or above, and write English;
* Physically able to participate.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Ann & Robert H Lurie Children's Hospital of Chicago
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elfriede Pahl, MD
Attending Physician, Division of Cardiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elfriede Pahl, MD
Role: PRINCIPAL_INVESTIGATOR
Ann and Robert Lurie Children's Hospital
Kathleen Grady, PhD
Role: PRINCIPAL_INVESTIGATOR
Northwestern University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Loma Linda University
Loma Linda, California, United States
Universtiy of Colorado Denver/Children Colorado
Aurora, Colorado, United States
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
Columbia University
New York, New York, United States
Children's Hospital of Philadelphia/University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.